Related Experiment Video

Updated: Jun 1, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Myoclonic astatic epilepsy and the use of the ketogenic diet

A G Christina Bergqvist1

  • 1Division of Neurology, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. bergqvist@email.chop.edu

Epilepsy Research
|June 3, 2011
PubMed

Insights

Myoclonic astatic epilepsy (MAE) is a rare childhood epilepsy. Dietary therapies, particularly the ketogenic diet (KD), show promise for managing this severe neurological condition.

Area of Science:

  • Neurology
  • Pediatric Epilepsy Syndromes
  • Dietary Therapies

Background:

  • Myoclonic astatic epilepsy (MAE) is a rare generalized epilepsy syndrome in children.
  • The exact incidence and etiology of MAE remain unknown.
  • MAE can present with explosive onset, diverse seizure types, and may lead to epileptic encephalopathy.

Purpose of the Study:

  • To review the background of Myoclonic Astatic Epilepsy (MAE).
  • To outline the diagnostic criteria for MAE.
  • To summarize current knowledge on dietary therapies for MAE.

Main Methods:

  • Literature review of existing studies on MAE.
  • Analysis of diagnostic criteria for MAE.
  • Compilation of data on the efficacy of dietary interventions in MAE patients.

Main Results:

  • MAE is a severe childhood epilepsy syndrome with unknown causes.
  • The ketogenic diet (KD) may be a particularly effective treatment for MAE.
  • Further research is needed to fully understand MAE and its treatment.

Conclusions:

  • Myoclonic astatic epilepsy (MAE) is a challenging epilepsy syndrome in children.
  • Dietary therapies, especially the ketogenic diet (KD), represent a promising treatment avenue for MAE.
  • Continued investigation into MAE and its therapeutic options is crucial.

More Related Videos

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types: